Searle & Co. Baxter International Inc Transaction History

Searle & Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$31.71 - $38.95 $63,420 - $77,900	-2,000 Reduced 5.93%	31,752 $1.23 Million
Q1 2023 Jun 01, 2023	SELL	$37.58 - $52.57 $20,481 - $28,650	-545 Reduced 1.59%	33,752 $1.37 Million
Q4 2022 Feb 03, 2023	SELL	$49.7 - $57.71 $91,298 - $106,013	-1,837 Reduced 5.08%	34,297 $1.75 Million
Q1 2022 May 10, 2022	SELL	$76.85 - $89.45 $7,684 - $8,945	-100 Reduced 0.28%	36,134 $2.8 Million
Q1 2021 May 12, 2021	BUY	$76.38 - $86.03 $3,819 - $4,301	50 Added 0.14%	36,234 $3.06 Million
Q4 2020 Feb 04, 2021	BUY	$75.39 - $82.36 $7,539 - $8,236	100 Added 0.28%	36,184 $2.9 Million
Q3 2019 Oct 22, 2019	SELL	$81.4 - $89.78 $1,302 - $1,436	-16 Reduced 0.04%	36,084 $3.16 Million
Q2 2018 Jul 19, 2018	BUY	$63.43 - $75.41 $285,435 - $339,345	4,500 Added 14.24%	36,100 $2.67 Million
Q3 2017 Oct 27, 2017	BUY	$59.5 - $64.61 $1.88 Million - $2.04 Million	31,600	31,600 $1.98 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

Stay updated on Searle & Co. with notifications on news.